Cambrex

CBM NYSE
44.99
-0.59
-1.29%
Closed 18:41 07/19 EDT
Open
45.57
Prev Close
45.58
High
46.11
Low
44.92
Volume
220.29K
Avg Vol (3M)
206.46K
52 Week High
69.43
52 Week Low
33.80
% Turnover
0.65%
Market Cap
1.51B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Cambrex CBM stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the subsidiaries, including Cambrex Charles City, Inc., Cambrex Karlskoga AB and Cambrex Profarmaco Milano S.r.l. Its products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It delivers services, such as custom organic synthesis and process development; current good manufacturing practices (cGMP) manufacturing of API and intermediates from grams to hundreds of kilograms; cGMP analytical services; controlled substance research and development (R&D) and manufacture, Schedule II-V, and contract research. It has API R&D and cGMP facilities in the United States and Europe. It supplies over 90 generic APIs.
MORE >

Recently

Name
Price
%Change